Skip to main content
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Eukaryotic Cell
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems
  • Log in
  • My alerts
  • My Cart

Main menu

  • Home
  • Articles
    • Current Issue
    • Accepted Manuscripts
    • COVID-19 Special Collection
    • Archive
    • Minireviews
  • For Authors
    • Submit a Manuscript
    • Scope
    • Editorial Policy
    • Submission, Review, & Publication Processes
    • Organization and Format
    • Errata, Author Corrections, Retractions
    • Illustrations and Tables
    • Nomenclature
    • Abbreviations and Conventions
    • Publication Fees
    • Ethics Resources and Policies
  • About the Journal
    • About AAC
    • Editor in Chief
    • Editorial Board
    • For Reviewers
    • For the Media
    • For Librarians
    • For Advertisers
    • Alerts
    • AAC Podcast
    • RSS
    • FAQ
  • Subscribe
    • Members
    • Institutions
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Eukaryotic Cell
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems

User menu

  • Log in
  • My alerts
  • My Cart

Search

  • Advanced search
Antimicrobial Agents and Chemotherapy
publisher-logosite-logo

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Accepted Manuscripts
    • COVID-19 Special Collection
    • Archive
    • Minireviews
  • For Authors
    • Submit a Manuscript
    • Scope
    • Editorial Policy
    • Submission, Review, & Publication Processes
    • Organization and Format
    • Errata, Author Corrections, Retractions
    • Illustrations and Tables
    • Nomenclature
    • Abbreviations and Conventions
    • Publication Fees
    • Ethics Resources and Policies
  • About the Journal
    • About AAC
    • Editor in Chief
    • Editorial Board
    • For Reviewers
    • For the Media
    • For Librarians
    • For Advertisers
    • Alerts
    • AAC Podcast
    • RSS
    • FAQ
  • Subscribe
    • Members
    • Institutions
Letter to the Editor

In Vitro Assessment of Antifungal Drugs and Sulfamethoxazole-Trimethoprim against Clinical Isolates of Conidiobolus lamprauges

Juliana S. M. Tondolo, Erico S. Loreto, Francielli P. K. Jesus, Valéria Dutra, Luciano Nakazato, Sydney H. Alves, Janio M. Santurio
Juliana S. M. Tondolo
aPrograma de Pós-Graduação em Farmacologia, Centro de Ciências da Saúde, Departamento de Microbiologia e Parasitologia, Universidade Federal de Santa Maria (UFSM), Santa Maria, Rio Grande do Sul, Brazil
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Juliana S. M. Tondolo
Erico S. Loreto
bPrograma de Pós-Graduação em Ciências Farmacêuticas, Centro de Ciências da Saúde, Departamento de Microbiologia e Parasitologia, Universidade Federal de Santa Maria (UFSM), Santa Maria, Rio Grande do Sul, Brazil
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Erico S. Loreto
Francielli P. K. Jesus
cPrograma de Pós-Graduação em Ciências Veterinárias, Universidade Federal do Rio Grande do Sul (UFRGS), Porto Alegre, Rio Grande do Sul, Brazil
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Valéria Dutra
dPrograma de Pós-Graduação em Ciências Veterinárias, Universidade Federal do Mato Grosso, Cuiabá, Mato Grosso, Brazil
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Luciano Nakazato
dPrograma de Pós-Graduação em Ciências Veterinárias, Universidade Federal do Mato Grosso, Cuiabá, Mato Grosso, Brazil
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sydney H. Alves
bPrograma de Pós-Graduação em Ciências Farmacêuticas, Centro de Ciências da Saúde, Departamento de Microbiologia e Parasitologia, Universidade Federal de Santa Maria (UFSM), Santa Maria, Rio Grande do Sul, Brazil
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Sydney H. Alves
Janio M. Santurio
aPrograma de Pós-Graduação em Farmacologia, Centro de Ciências da Saúde, Departamento de Microbiologia e Parasitologia, Universidade Federal de Santa Maria (UFSM), Santa Maria, Rio Grande do Sul, Brazil
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DOI: 10.1128/AAC.01685-17
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

LETTER

Conidiobolomycosis is an infection for which there are no sufficient clinical or in vitro data to support a consensus about the optimal treatment, and consequently, cases of therapeutic success and failure have been described for all forms of therapy (1–3). We have determined the in vitro activities of sulfamethoxazole, trimethoprim, and several antifungal drugs alone and in combination against Conidiobolus lamprauges, a pathogenic agent of nasopharyngeal conidiobolomycosis in animals (4, 5) and in one case of disseminated human disease (3).

Seven nonduplicate C. lamprauges isolates obtained from cases of sheep rhino-conidiobolomycosis from central-western Brazil, previously identified based on their macro- and microscopic characteristics (6) as well as the nucleotide sequences of their 18S ribosomal DNA (rDNA) genes (7), were used. The sequences obtained were analyzed, and multiple-sequence alignment was done with Conidiobolus coronatus, C. lamprauges, and Conidiobolus incongruus reference strains. The antimicrobials used in the susceptibility tests are described in Table 1. Broth microdilution susceptibility tests were performed by following the CLSI M38-A2 protocol (8, 9), except with the final inocula, which were diluted 1:10 to produce more consistent mycelial growth for the determination of MIC endpoints. The interactions between drugs were evaluated using a checkerboard test (10) and by a colorimetric 2,3-bis-(2-methoxy-4-nitro-5-sulfophenyl)-2H-tetrazolium-5-carboxanilide salt (XTT) time-kill assay (11).

View this table:
  • View inline
  • View popup
TABLE 1

In vitro susceptibilities of sulfamethoxazole, trimethoprim, and antifungal drugs alone and in combination against seven Conidiobolus lamprauges isolatesa

The MICs and minimum effective concentrations (MECs) of the antimicrobial drugs evaluated against C. lamprauges are presented in Table 1. Amphotericin B (MIC100 range, 1 to 2 μg/ml), terbinafine (MIC100 range, 1 to 4, and MIC80, 0.06 to 2 μg/ml), and miconazole (MIC100 range, 4 to 16 μg/ml) were considered the most effective drugs because they required the lowest concentrations for the in vitro inhibition of C. lamprauges. Checkerboard results (Table 1) showed synergistic interactions of 100% for the sulfamethoxazole-trimethoprim combination, 71% for the terbinafine-azole antifungal combinations, and 29% for the terbinafine-micafungin combination. All other interactions were indifferent. An XTT reduction assay showed significantly greater hyphal damage for the sulfamethoxazole-trimethoprim combination than for drugs used alone (Fig. 1A and B), but levels of hyphal viability after terbinafine treatment and after treatment with azole antifungals did not differ significantly (Fig. 1C).

FIG 1
  • Open in new tab
  • Download powerpoint
FIG 1

XTT reduction assay. Percentages of viable hyphae of C. lamprauges exposed to sulfamethoxazole (SMX), trimethoprim (TMP), terbinafine (TRB), miconazole (MCZ), posaconazole (POS), and voriconazole (VOR) at different concentrations (micrograms per milliliter) alone and in combination. Data represent the means ± standard errors of the means from seven strains in triplicate. Hyphal viability was determined at 12, 24, and 48 h of incubation at 37°C. Data were subjected to logarithmic transformation to obtain homogeneity between groups and were analyzed by one-way analysis of variance with the Holm-Sidak test for statistical comparisons between drug combination groups versus groups in which the drug was used alone. The statistics program SigmaPlot 12.5 was used for data analysis. An asterisk indicates a significant difference (P ≤ 0.01), and a hashtag indicates a significant difference (P < 0.001) from the groups in which a drug was used alone.

Susceptibility tests for C. lamprauges have previously been described in only a few reports (3, 9, 12), and these presented results similar to those obtained through this study. Previous works demonstrate the preventive and therapeutic potential of sulfamethoxazole-trimethoprim against Pneumocystis, Aspergillus, and Cryptococcus species (13, 14), suggesting that these drugs may also have potentially been used for the treatment of conidiobolomycosis.

In conclusion, the in vitro data reported here suggest that the combinations of sulfamethoxazole-trimethoprim and terbinafine alone or associated with azole antifungal drugs deserve attention as candidates for the treatment of conidiobolomycosis infections. Additional in vitro and in vivo studies with a large number of clinical isolates and antimicrobial combinations are needed to better understand the susceptibility of C. lamprauges to the antimicrobials described in this study.

Accession number(s).Nucleotide data for the 3 isolates were deposited in GenBank under accession numbers GQ221848, GQ221849, and GQ217491. All strains were deposited in the Culture Collection of Filamentous Fungi (Fiocruz, RJ, Brazil) with additional internal transcribed spacer sequence analysis (data not shown).

  • Copyright © 2018 American Society for Microbiology.

All Rights Reserved.

REFERENCES

  1. 1.↵
    1. Prabhu RM,
    2. Patel R
    . 2004. Mucormycosis and entomophthoramycosis: a review of the clinical manifestations, diagnosis and treatment. Clin Microbiol Infect 10:31–47. doi:10.1111/j.1470-9465.2004.00843.x.
    OpenUrlCrossRefPubMedWeb of Science
  2. 2.↵
    1. Reiss E,
    2. Shadomy HJ,
    3. Lyon GM
    . 2012. Entomophthoramycosis caused by Conidiobolus species, p 467–474. In Reiss E, Shadomy HJ, Lyon GM (ed), Fundamental medical mycology, 1st ed. John Wiley & Sons, Hoboken, NJ.
  3. 3.↵
    1. Kimura M,
    2. Yaguchi T,
    3. Sutton DA,
    4. Fothergill AW,
    5. Thompson EH,
    6. Wickes BL
    . 2011. Disseminated human conidiobolomycosis due to Conidiobolus lamprauges. J Clin Microbiol 49:752–756. doi:10.1128/JCM.01484-10.
    OpenUrlAbstract/FREE Full Text
  4. 4.↵
    1. Furlan FH,
    2. Lucioli J,
    3. Veronezi LO,
    4. Fonteque JH,
    5. Traverso SD,
    6. Nakazato L,
    7. Gava A
    . 2010. Conidiobolomycosis caused by Conidiobolus lamprauges in sheep in the state of Santa Catarina, Brazil. Pesq Vet Bras 30:529–532. doi:10.1590/S0100-736X2010000700003.
    OpenUrlCrossRef
  5. 5.↵
    1. Humber RA,
    2. Brown CC,
    3. Kornegay RW
    . 1989. Equine zygomycosis caused by Conidiobolus lamprauges. J Clin Microbiol 27:573–576.
    OpenUrlAbstract/FREE Full Text
  6. 6.↵
    1. Vilela R,
    2. Silva SM,
    3. Riet-Correa F,
    4. Dominguez E,
    5. Mendoza L
    . 2010. Morphologic and phylogenetic characterization of Conidiobolus lamprauges recovered from infected sheep. J Clin Microbiol 48:427–432. doi:10.1128/JCM.01589-09.
    OpenUrlAbstract/FREE Full Text
  7. 7.↵
    1. de Paula DA,
    2. de Oliveira Filho JX,
    3. da Silva MC,
    4. Colodel EM,
    5. Broetto L,
    6. Pinto PM,
    7. Schrank A,
    8. Nakazato L,
    9. Dutra V
    . 2010. Molecular characterization of ovine zygomycosis in central western Brazil. J Vet Diagn Invest 22:274–277. doi:10.1177/104063871002200220.
    OpenUrlCrossRefPubMed
  8. 8.↵
    Clinical and Laboratory Standards Institute. 2008. Reference method for broth dilution antifungal susceptibility testing of filamentous fungi; approved standard. CLSI document M38-A2, 2nd ed. Clinical and Laboratory Standards Institute, Wayne, PA.
  9. 9.↵
    1. Tondolo JS,
    2. de Loreto ES,
    3. Dutra V,
    4. Nakazato L,
    5. de Paula DA,
    6. Zanette RA,
    7. Alves SH,
    8. Santurio JM
    . 2013. In vitro susceptibility of Conidiobolus lamprauges recovered from sheep to antifungal agents. Vet Microbiol 166:690–693. doi:10.1016/j.vetmic.2013.07.024.
    OpenUrlCrossRefPubMed
  10. 10.↵
    1. Moody J
    . 2007. Synergism testing: broth microdilution checkerboard and broth macrodilution methods, p 1–23. In Garcia LS, Isenberg HD (ed), Clinical microbiology procedures handbook, 2nd ed. ASM Press, Washington, DC.
  11. 11.↵
    1. Ben-Ami R,
    2. Lewis RE,
    3. Tarrand J,
    4. Leventakos K,
    5. Kontoyiannis DP
    . 2010. Antifungal activity of colistin against mucorales species in vitro and in a murine model of Rhizopus oryzae pulmonary infection. Antimicrob Agents Chemother 54:484–490. doi:10.1128/AAC.00956-09.
    OpenUrlAbstract/FREE Full Text
  12. 12.↵
    1. Guarro J,
    2. Aguilar C,
    3. Pujol I
    . 1999. In vitro antifungal susceptibilities of Basidiobolus and Conidiobolus spp. strains. J Antimicrob Chemother 44:557–560. doi:10.1093/jac/44.4.557.
    OpenUrlCrossRefPubMedWeb of Science
  13. 13.↵
    1. Hanafy A,
    2. Uno J,
    3. Mitani H,
    4. Kang Y,
    5. Mikami Y
    . 2007. In vitro antifungal activities of sulfa drugs against clinical isolates of Aspergillus and Cryptococcus species. Nihon Ishinkin Gakkai Zasshi 48:47–50. doi:10.3314/jjmm.48.47.
    OpenUrlCrossRef
  14. 14.↵
    1. Utili R,
    2. Durante-Mangoni E,
    3. Basilico C,
    4. Mattei A,
    5. Ragone E,
    6. Grossi P
    . 2007. Efficacy of caspofungin addition to trimethoprim-sulfamethoxazole treatment for severe pneumocystis pneumonia in solid organ transplant recipients. Transplantation 84:685–688. doi:10.1097/01.tp.0000280546.91617.6c.
    OpenUrlCrossRefPubMedWeb of Science
PreviousNext
Back to top
Download PDF
Citation Tools
In Vitro Assessment of Antifungal Drugs and Sulfamethoxazole-Trimethoprim against Clinical Isolates of Conidiobolus lamprauges
Juliana S. M. Tondolo, Erico S. Loreto, Francielli P. K. Jesus, Valéria Dutra, Luciano Nakazato, Sydney H. Alves, Janio M. Santurio
Antimicrobial Agents and Chemotherapy Mar 2018, 62 (4) e01685-17; DOI: 10.1128/AAC.01685-17

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Print

Alerts
Sign In to Email Alerts with your Email Address
Email

Thank you for sharing this Antimicrobial Agents and Chemotherapy article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
In Vitro Assessment of Antifungal Drugs and Sulfamethoxazole-Trimethoprim against Clinical Isolates of Conidiobolus lamprauges
(Your Name) has forwarded a page to you from Antimicrobial Agents and Chemotherapy
(Your Name) thought you would be interested in this article in Antimicrobial Agents and Chemotherapy.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
In Vitro Assessment of Antifungal Drugs and Sulfamethoxazole-Trimethoprim against Clinical Isolates of Conidiobolus lamprauges
Juliana S. M. Tondolo, Erico S. Loreto, Francielli P. K. Jesus, Valéria Dutra, Luciano Nakazato, Sydney H. Alves, Janio M. Santurio
Antimicrobial Agents and Chemotherapy Mar 2018, 62 (4) e01685-17; DOI: 10.1128/AAC.01685-17
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Top
  • Article
    • LETTER
    • REFERENCES
  • Figures & Data
  • Info & Metrics
  • PDF

KEYWORDS

conidiobolomycosis
susceptibility testing
terbinafine
sulfamethoxazole
trimethoprim

Related Articles

Cited By...

About

  • About AAC
  • Editor in Chief
  • Editorial Board
  • Policies
  • For Reviewers
  • For the Media
  • For Librarians
  • For Advertisers
  • Alerts
  • AAC Podcast
  • RSS
  • FAQ
  • Permissions
  • Journal Announcements

Authors

  • ASM Author Center
  • Submit a Manuscript
  • Article Types
  • Ethics
  • Contact Us

Follow #AACJournal

@ASMicrobiology

       

ASM Journals

ASM journals are the most prominent publications in the field, delivering up-to-date and authoritative coverage of both basic and clinical microbiology.

About ASM | Contact Us | Press Room

 

ASM is a member of

Scientific Society Publisher Alliance

 

American Society for Microbiology
1752 N St. NW
Washington, DC 20036
Phone: (202) 737-3600

Copyright © 2021 American Society for Microbiology | Privacy Policy | Website feedback

Print ISSN: 0066-4804; Online ISSN: 1098-6596